BackSilverback Therapeutics Overview

Silverback Therapeutics Current Assets

Track Silverback Therapeutics's current assets ($250M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$245.24M
↓ 19.29% YoYΔ $-58.62M vs prior year quarter

Peer average

Loading

Silverback Therapeutics Current Assets History

Loading

Silverback Therapeutics vs. peers: Current Assets Comparison

Loading

Silverback Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Silverback Therapeutics (SBTX) FAQ

As of the most recent data (March 2026), SBTX shows a current assets of $250M. That compares with $300M in the prior-year period — down 19.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SBTX's current assets is now $250M (was $300M) — a 19.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Silverback Therapeutics is outperforming or lagging.

Tracking SBTX's current assets over time shows whether Silverback Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $250M That compares with $300M in the prior-year period — down 19.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Silverback Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $250M) with ownership activity and broader fundamentals.

Silverback Therapeutics's current assets is $250M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.